PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE

May 1, 2005, 00:00
10.1016/S1098-3015(10)62953-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)62953-1/fulltext
Title : PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62953-1&doi=10.1016/S1098-3015(10)62953-1
First page :
Section Title :
Open access? : No
Section Order : 390
Categories :
Tags :
Regions :
ViH Article Tags :